Next Article in Journal
Common Motor Drive Triggers Response of Prime Movers When Two Fingers Simultaneously Respond to a Cue
Previous Article in Journal
EEG-Based Tool for Prediction of University Students’ Cognitive Performance in the Classroom
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Brain Sciences
Volume 11
Issue 6
10.3390/brainsci11060699
brainsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury

by
Seong Phil Bae
1,
Seung Han Shin
2,*,
Young Mi Yoon
3,
Ee-Kyung Kim
2 and
Han-Suk Kim
2
1
Department of Pediatrics, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul 04401, Korea
2
Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul 03080, Korea
3
Department of Pediatrics, Jeju National University Hospital, Jeju University School of Medicine, Jeju 63241, Korea
*
Author to whom correspondence should be addressed.
Brain Sci. 2021, 11(6), 699; https://doi.org/10.3390/brainsci11060699
Submission received: 19 April 2021 / Revised: 19 May 2021 / Accepted: 25 May 2021 / Published: 26 May 2021
Browse Figure
Versions Notes

Abstract

Although impaired neurodevelopment is strongly associated with severe brain injury, most preterm infants survive without severe brain injury. In this study, the association of impaired neurodevelopment and neonatal morbidities of preterm infants was assessed after excluding those with severe brain injury. This was a retrospective study of very low birthweight infants in a single tertiary center. After excluding infants with severe brain injury, the study population was categorized as infants without intraventricular hemorrhage (IVH) and with low-grade IVH. Neurodevelopmental outcomes at a corrected age (CA) of 18–24 months were evaluated using the Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III). Cerebral palsy (CP), hearing impairment and blindness were also assessed and compared. Of 240 infants, 25 (11.6%) infants had combined neurodevelopmental impairment (NDI). In the multivariate analysis for combined NDI, small for gestational age (SGA) (adjusted OR 6.820, 95% confidence intervals (CI) 1.770–26.307), moderate to severe bronchopulmonary dysplasia (BPD) (aOR 3.21, 95% CI 1.032–9.999) and severe retinopathy of prematurity (ROP) (aOR 5.669, 95% CI 1.132–28.396) were associated with combined NDI. Among neonatal morbidities, moderate to severe BPD and severe ROP were associated with adverse neurodevelopmental outcomes in preterm infants without severe brain injury.

1. Introduction

Severe brain injury, such as high-grade intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL), is the most important determinant of adverse neurodevelopmental outcomes in preterm infants [1,2]. However, only 9.4 ~ 13% of very preterm infants experience such brain injury during the neonatal period, while most preterm infants have no brain injury or only mild brain injury, such as low-grade IVH [3,4,5]. Given an impaired neurodevelopment rate of 5 ~ 15%, even in preterm infants without severe brain injury, it is necessary to identify predictors for adverse neurodevelopmental outcomes in this population [1,6,7].
Apart from severe brain injuries in preterm infants, the role of low-grade IVH in neurodevelopment has been controversial. One of the largest cohort studies of preterm infants showed that the incidence of cerebral palsy (CP) at two years of age, in infants with low-grade IVH, was higher than that in infants without any IVH [8]. In a single-center study of ELBW infants, the low-grade IVH group had better neurodevelopmental outcomes at 20 months than the no IVH group [9]. However, some studies have reported that low-grade IVH did not increase the risk of adverse neurodevelopmental outcomes [10,11].
Alternatively, other neonatal morbidities in preterm infants have been reportedly associated with adverse outcomes in short-term and long-term periods. Sepsis and necrotizing enterocolitis (NEC) were associated with adverse neurodevelopmental outcomes, which might be mediated by the degree of white matter injuries [12,13]. Bronchopulmonary dysplasia (BPD) and a longer duration of invasive ventilation were associated with growth retardation and impaired neurodevelopment [14,15]. Adverse neurodevelopment was frequently found in preterm infants with retinopathy of prematurity (ROP), especially with severe disease, with or without visual impairment [16,17]. However, these associations have been demonstrated in preterm infants, including populations of preterm infants with or without severe brain injuries. As infants with those morbidities were more likely to have brain injuries, which are highly associated with adverse neurodevelopment, it is worthwhile to investigate the association of neonatal morbidities with neurodevelopmental outcomes after excluding severe brain injuries in preterm infants.
The aim of the current study was to evaluate whether adverse neurodevelopmental outcomes are associated with low-grade IVH compared with no IVH, and to evaluate the associations of other neonatal morbidities, such as sepsis, NEC, BPD and ROP, with neurodevelopmental impairment (NDI) in very low birth weight (VLBW) infants without severe brain injury.

2. Materials and Methods

Preterm infants born between January 2015 and December 2017 with a birthweight of less than 1500 g were enrolled in the study. Infants who had major congenital anomalies or severe brain injuries, such as high-grade IVH and PVL, were excluded from the study population. Those who died or were transferred to other hospitals before discharge and those with missing medical records were excluded from the study population. The study population was categorized as the no IVH group and low IVH group, which was diagnosed with brain sonography (USG) and/or brain magnetic resonance imaging (MRI).
Small for gestational age corresponds to birth weight below the 3rd percentile for gestational age at birth according to INTERGROWTH-21st standard [18]. Bronchopulmonary dysplasia (BPD) was defined when respiratory support and/or oxygen supplementation was required at 36 weeks of postmenstrual age (PMA) [19]. Treated patent ductus arteriosus (PDA) was defined as symptomatic PDA requiring medical or surgical treatment. Retinopathy of prematurity (ROP) was staged according to the International Classification of ROP, and severe ROP was defined as those with a treatment threshold in stage III or higher, or in rapidly progressive disease requiring laser photocoagulation [20]. Necrotizing enterocolitis (NEC) was defined as stage II or higher, according to Bell’s Staging Criteria [21]. Experienced pediatric radiologists performed brain USG using Papile’s classification to determine the grade of IVH [22], and grades I or II were defined as low-grade IVH, while grade III or more was defined as high-grade IVH. A brain magnetic MRI at term-equivalent age was performed if significant brain injury was suspected or the birth weight was less than 1000 g.
The Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III) results at a CA of 18–24 months were reviewed for each group to evaluate neurodevelopmental outcomes. On the Bayley-III, scores of less than 85 (<−1 SD) in both the cognitive and language domains, or a motor score of less than 85, were defined as developmental delay [23]. Hearing impairment was defined as the need for unilateral or bilateral hearing aids. Infants who met any of the following criteria at a CA of 18–24 months were defined as having combined NDI and were included in the NDI group: delay in Bayley-III, cerebral palsy (CP), hearing impairment or blindness [24]. This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1511-006-713). The need for informed consent was also waived by the Institutional Review Board of Seoul National University Hospital, and methods were carried out in accordance with relevant guidelines and regulations.
Statistical analyses were performed using Predictive Analytics SoftWare Statistics (v21.0; IBM SPSS Statistics, IBM Corporation, Armonk, NY, USA). To analyze the population characteristics, categorical data were assessed using the chi-squared test and Fisher’s exact test. Continuous data were analyzed by Student’s t-test and the Wilcoxon rank-sum test. Neonatal morbidities such as RDS, treated PDA, moderate to severe BPD, severe ROP, NEC and sepsis, as well as gestational age and small for gestational age, were subjected to multivariate logistic regression analysis for combined NDI. To treat multicollinearity, the variance inflation factor (VIF) was calculated, and covariates of VIF > 10 were not included in the multivariate analysis. Goodness of fit was evaluated by the Hosmer–Lemeshow test. Multivariate logistic regression was performed after excluding infants who were not tested by Bayley-III at follow-up as a sensitivity analysis and is provided in the supplementary materials.

3. Results

Of the 320 VLBW infants, 21 infants with severe brain injury, 41 infants who died in the NICU, 10 infants who were transferred to other hospitals and 7 infants who had major congenital anomalies were excluded from the study (Figure 1). Among the study population, 45 (18.8%) had low-grade IVH, and 25 (11.6%) infants had combined NDI at follow-up.
Gestational age (30.3 vs. 28.4 weeks, p < 0.001) and birthweight (1230 vs. 920 g, p < 0.001) were lower in the low-grade IVH group (Table 1).
Otherwise, there were no significant differences in the perinatal characteristics. RDS was more prevalent in the low-grade IVH group (41.0% vs. 71.1%, p < 0.001), and days of hospitalization were longer in the low-grade IVH group (53 vs. 73 days, <0.001) (Table 2). Other neonatal morbidities were comparable between the two groups.
Combined neurodevelopmental impairment was comparable between the two groups (Table 3).
There was only one case of CP, although a brain MRI at term equivalent age showed no additional injuries, such as cerebellar hemorrhage or white matter injury. There was no case of hearing loss requiring hearing aids, and there was no case of blindness. In Bayley-III at CA 18–24 months, scores of the language domain were lower in the low-grade IVH group, while scores of the cognitive and motor domains were comparable between groups. However, according to the predefined category in developmental delay, there were no differences in the delay of cognitive and language domains, or motor domains, between the two groups. There was no difference in combined NDI between the two groups.
In the univariate analysis, SGA, moderate to severe BPD, severe ROP and sepsis were associated with combined NDI in the study population (Table 4). Multivariate analysis showed that SGA (adjusted OR (aOR) 6.820, 95% confidence intervals (CI) 1.770–26.307), moderate to severe BPD (aOR 3.21, 95% CI 1.032–9.999) and severe ROP (aOR 5.669, 95% CI 1.132–28.396) were associated with combined NDI (goodness of fit, p = 0.381).
Among 16 infants with severe ROP, there were no cases of blindness of any eye. Only one infant was prescribed eyeglasses, owing to myopia of both eyes, and had no combined NDI at follow-up. After excluding 58 infants without Bayley-III at follow-up, multivariate analysis also showed that SGA and severe ROP were associated with combined NDI (goodness of fit, p = 0.576) (Table S2).

4. Discussion

In the current study, 11.6% of VLBW infants without severe brain injury experienced NDI at CA 18–24 months, and there were no differences in NDI between the low-grade IVH group and the no IVH group. Among other neonatal morbidities, SGA, moderate to severe BPD and severe ROP were associated with NDI, although no case of blindness was noted in the study sample. The prevalence of NDI among preterm infants without severe brain injury was comparable with previous studies, as Bolisetty et al. reported that moderate to severe NDI occurred in 13.5% of extremely preterm infants [1], and Payne et al. reported that moderate to severe developmental impairment was found in 10 ~ 30% of extremely preterm infants without high-grade IVH [25].
The association of SGA and adverse neurodevelopment has been well demonstrated in term infants [26,27]. Recently, studies also reported that birth as SGA or intrauterine growth restriction was associated with growth restriction of the brain and adverse neurodevelopment in preterm infants [28,29]. The association of BPD developmental impairment has also been well demonstrated [30,31,32]. Schmidt et al. suggested that BPD affects later death or disability at five years of age, with an odds ratio similar to that of brain injury [33].
Retinopathy of prematurity (ROP) is frequently found in preterm infants with low gestational ages and is associated with adverse neurodevelopmental outcomes, especially in severe diseases [16,33]. However, severe ROP is also associated with the presence of severe IVH [34,35]. Given that several conditions in preterm infants, such as tissue ischemia, vascular immaturity and oxidative stress, are associated with these two conditions [36,37], studies reporting the association between severe ROP and NDI included up to 10 ~ 50% infants with severe brain injury in the study population [16,33,38]. Therefore, excluding those with severe brain injury might be helpful to clarify the association between severe ROP and NDI more clearly, as shown in this study.
One of the hypotheses to explain the association between neurodevelopment and ROP is that visual impairment might mediate neurodevelopmental impairment (NDI) in preterm infants with severe ROP [39,40,41]. Early childhood sensory experience after brain damage affects the reorganization of synapses through neuroplasticity and thereby affects high-order cognitive function [42,43]. However, in the current study, there were no infants with blindness or deafness. Only one infant was prescribed eyeglasses, but the infant had no NDI at follow-up. Rather, the association between severe ROP and nonvisual disabilities might originate from unfavorable exposures that promote the development of retinopathy and may simultaneously have a negative effect on brain plasticity [17]. In studies with brain MRI at term-equivalent age, severe ROP was associated with a delay in white matter maturation and reduced brain volume [16,41].
Another interesting finding is that low-grade IVH was not associated with neurodevelopmental impairment in this study. There have been studies reporting the association of low-grade IVH with neurodevelopmental outcomes [7,9]. However, Payne et al. reported that the neurodevelopmental outcomes at 18 to 22 months CA of preterm infants who were born at less than 27 weeks of gestation with low-grade IVH were not different from those without hemorrhage. A report from de Vries et al. also illustrated comparable outcomes between the low-grade IVH group and the control group [6]. Those studies regarding the association of low-grade IVH and neurodevelopmental outcomes did not consider ROP as a cofounding factor. Only the study by Klebermass-Schrehof et al. reported the prevalence of severe ROP between low-grade IVH and no IVH, but severe ROP was not considered when comparing outcomes [7]. The present study investigated the impact of low-grade IVH, as well as severe ROP, and showed no association of low-grade IVH and neurodevelopment outcomes. However, the results of the current study should be interpreted with caution, as the incidence of low-grade IVH among the study population without severe brain injury was relatively lower (18.8%) than previous studies (26 ~ 40%), with relatively low incidence of NDI [1,7,9,25]. This might be attributed by different study populations, as more mature preterm infants were included in the current study. Although there was a discrepancy of the number of participants between groups, incidence of low-grade IVH was adjusted with other factors to calculate adjusted odds for NDI as a study outcome.
There are several limitations to this study. First, among 240 VLBW infants without severe brain injury, only 182 (75.8%) were evaluated by Bayley-III. When infants without Bayley-III scores were excluded as a sensitivity analysis, multiple logistic regression analysis found that severe ROP and SGA were still associated with NDI (Table S2). Second, data were not available on socioenvironmental influences, such as the education level and socioeconomic status of the parents.

5. Conclusions

Among VLBW infants without severe brain injury, 11.6% had NDI at CA 18–24 months. Severe ROP with a treatment threshold and moderate to severe BPD were associated with NDI. However, no case of blindness was identified. As severe brain injury, as a strong predictor of NDI, was excluded in the study population, the role of ROP and BPD in neurodevelopment might be clearer in this study.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/brainsci11060699/s1, Table S1: Perinatal and neonatal characteristics of study population after excluding infants without Bayley-III; Table S2: Univariate and multivariate analysis for combined neurodevelopmental impairment after excluding infants who were not tested with Bayley-III at 18–24 months of corrected age.

Author Contributions

Conceptualization: S.P.B. and S.H.S.; methodology, S.H.S.; software, S.H.S.; validation, Y.M.Y.; formal analysis, S.P.B.; investigation, S.P.B. and S.H.S.; resources, H.-S.K.; data curation, S.P.B. and Y.M.Y.; writing—original draft preparation, S.P.B.; writing—review and editing, S.H.S., E.-K.K. and H.-S.K.; visualization, Y.M.Y. and S.H.S.; supervision, E.-K.K. and H.-S.K.; Project administration, S.H.S.; funding acquisition, S.P.B., E.-K.K. and H.-S.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Soonchunhyang University Research Fund, grant number 10210013.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1511-006-713).

Informed Consent Statement

Patient consent was waived due to a retrospective study that did not include personally identifiable information on the subjects and met the consent exemption criteria.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to personal medical records.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Bolisetty, S.; Dhawan, A.; Abdel-Latif, M.; Bajuk, B.; Stack, J.; Oei, J.-L.; Lui, K.; New South Wales and Australian Capital Territory Neonatal Intensive Care Units Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014, 133, 55–62. [Google Scholar] [CrossRef] [PubMed]
  2. O’Shea, T.M.; Kuban, K.C.K.; Allred, E.N.; Paneth, N.; Pagano, M.; Dammann, O.; Bostic, L.; Brooklier, K.; Butler, S.; Goldstein, D.J.; et al. Neonatal cranial ultrasound lesions and developmental delays at 2 years of age among extremely low gestational age children. Pediatrics 2008, 122, e662–e669. [Google Scholar] [CrossRef] [PubMed]
  3. Adams-Chapman, I.; Hansen, N.I.; Stoll, B.J.; Higgins, R. For the NICHD research network neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics 2008, 121, e1167–e1177. [Google Scholar] [CrossRef]
  4. Lee, J.; Hong, M.; Yum, S.K.; Lee, J.H. Perinatal prediction model for severe intraventricular hemorrhage and the effect of early postnatal acidosis. Child’s Nerv. Syst. 2018, 34, 2215–2222. [Google Scholar] [CrossRef] [PubMed]
  5. Sherlock, R.; Anderson, P.; Doyle, L. Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELBW/very preterm infants. Early Hum. Dev. 2005, 81, 909–916. [Google Scholar] [CrossRef] [PubMed]
  6. Reubsaet, P.; Brouwer, A.J.; Van Haastert, I.C.; Brouwer, M.J.; Koopman, C.; Groenendaal, F.; De Vries, L.S. The impact of low-grade germinal matrix-intraventricular hemorrhage on neurodevelopmental outcome of very preterm infants. Neonatology 2017, 112, 203–210. [Google Scholar] [CrossRef]
  7. Klebermass-Schrehof, K.; Czaba, C.; Olischar, M.; Fuiko, R.; Waldhoer, T.; Rona, Z.; Pollak, A.; Weninger, M. Impact of low-grade intraventricular hemorrhage on long-term neurodevelopmental outcome in preterm infants. Child’s Nerv. Syst. 2012, 28, 2085–2092. [Google Scholar] [CrossRef] [PubMed]
  8. Ancel, P.-Y.; Livinec, F.; Larroque, B.; Marret, S.; Arnaud, C.; Pierrat, V.; Dehan, M.; N′guyen, S.; Escande, B.; Burguet, A.; et al. Cerebral Palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: The EPIPAGE cohort study. Pediatrics 2006, 117, 828–835. [Google Scholar] [CrossRef] [PubMed]
  9. Patra, K.; Wilson-Costello, D.; Taylor, H.G.; Mercuri-Minich, N.; Hack, M. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: Effects on neurodevelopment. J. Pediatr. 2006, 149, 169–173. [Google Scholar] [CrossRef] [PubMed]
  10. Bendersky, M.; Lewis, M. Effects of intraventricular hemorrhage and other medical and environmental risks on multiple out-comes at age three years. J. Dev. Behav. Pediatr. 1995, 16, 89–96. [Google Scholar] [CrossRef] [PubMed]
  11. Pinto-Martin, J.A.; Whitaker, A.H.; Feldman, J.F.; Van Rossem, R.; Paneth, N. Relation of cranial ultrasound abnormalities in low-birthweight infants to motor or cognitive performance at ages 2, 6, and 9 years. Dev. Med. Child Neurol. 1999, 41, 826–833. [Google Scholar] [CrossRef] [PubMed]
  12. Stoll, B.J.; Hansen, N.I.; Adams-Chapman, I.; Fanaroff, A.A.; Hintz, S.R.; Vohr, B.; Higgins, R.D. For the National Institute of Child Health and human development neonatal research network neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292, 2357–2365. [Google Scholar] [CrossRef]
  13. Shah, D.K.; Doyle, L.W.; Anderson, P.J.; Bear, M.; Daley, A.J.; Hunt, R.W.; Inder, T.E. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J. Pediatr. 2008, 153, 170–175.e1. [Google Scholar] [CrossRef]
  14. DeMauro, S.B. Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 2021. [Google Scholar] [CrossRef] [PubMed]
  15. Gallini, F.; Coppola, M.; De Rose, D.U.; Maggio, L.; Arena, R.; Romano, V.; Cota, F.; Ricci, D.; Romeo, D.M.; Mercuri, E.M.; et al. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia. Early Hum. Dev. 2021, 152, 105275. [Google Scholar] [CrossRef] [PubMed]
  16. Glass, A.; Chau, T.J.; Gardiner, V.; Foong, J.; Vinall, J.; Zwicker, J.; Grunau, J.G.E.; Synnes, R.; Poskitt, A.; Miller, K.J.S. Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment. Arch. Dis. Child. Fetal Neonatal Ed. 2017, 102, F532–F537. [Google Scholar] [CrossRef]
  17. Schmidt, B.; Davis, P.G.; Asztalos, E.V.; Solimano, A.; Roberts, R.S. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA 2014, 311, 523–525. [Google Scholar] [CrossRef]
  18. Villar, J.; Giuliani, F.; Fenton, T.R.O.; Ohuma, E.; Ismail, L.C.; Kennedy, S.H. INTERGROWTH-21st very preterm size at birth reference charts. Lancet 2016, 387, 844–845. [Google Scholar] [CrossRef]
  19. Jobe, A.H.; Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001, 163, 1723–1729. [Google Scholar] [CrossRef] [PubMed]
  20. Gole, A.; Ells, G.; Katz, A.L.; Holmstrom, X.; Fielder, G.; Capone, A.R.; Flynn, A.; Good, J.T.; Holmes, W.G.J.; McNamara, A.J.; et al. The International Classification of Retinopathy of Prematurity Revisited. Arch. Ophthalmol. 2005, 123, 991–999. [Google Scholar] [CrossRef]
  21. Bell, M.J.; Ternberg, J.L.; Feigin, R.D.; Keating, J.P.; Marshall, R.; Barton, L.; Brotherton, T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 1978, 187, 1–7. [Google Scholar] [CrossRef] [PubMed]
  22. Papile, L.-A.; Burstein, J.; Burstein, R.; Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1500 gm. J. Pediatr. 1978, 92, 529–534. [Google Scholar] [CrossRef]
  23. Johnson, S.; Moore, T.; Marlow, N. Using the Bayley-III to assess neurodevelopmental delay: Which cut-off should be used? Pediatr. Res. 2014, 75, 670–674. [Google Scholar] [CrossRef] [PubMed]
  24. Kilbride, H.W.; Aylward, G.P.; Doyle, L.W.; Singer, L.T.; Lantos, J. Prognostic neurodevelopmental testing of preterm infants: Do we need to change the paradigm? J. Perinatol. 2017, 37, 475–479. [Google Scholar] [CrossRef] [PubMed]
  25. Payne, A.H.; Hintz, S.R.; Hibbs, A.M.; Walsh, M.C.; Vohr, B.R.; Bann, C.M.; Wilson-Costello, D.E. For the Eunice Kennedy Shriver National Institute of Child Health and Human Development neonatal research network neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage. JAMA Pediatr. 2013, 167, 451–459. [Google Scholar] [CrossRef] [PubMed]
  26. Graz, M.B.; Tolsa, J.-F.; Fumeaux, C.J.F. Being Small for Gestational Age: Does it Matter for the Neurodevelopment of Premature Infants? A Cohort Study. PLoS ONE 2015, 10, e0125769. [Google Scholar] [CrossRef]
  27. Jelliffe-Pawlowski, L.L.; Hansen, R.L. Neurodevelopmental outcome at 8 months and 4 years among infants born full-term small-for-gestational-age. J. Perinatol. 2004, 24, 505–514. [Google Scholar] [CrossRef] [PubMed][Green Version]
  28. Lodygensky, A.; Seghier, G.; Warfield, M.L.; Tolsa, S.K.; Sizonenko, C.B.; Lazeyras, S.; Hüppi, F.P.S. Intrauterine growth restriction affects the preterm infant’s hippocampus. Pediatr. Res. 2008, 63, 438–443. [Google Scholar] [CrossRef]
  29. Beaino, G.; Khoshnood, B.; Kaminski, M.; Marret, S.; Pierrat, V.; Vieux, R.; Thiriez, G.; Matis, J.; Picaud, J.-C.; Rozé, J.-C.; et al. Predictors of the risk of cognitive deficiency in very preterm infants: The EPIPAGE prospective cohort. Acta Paediatr. 2011, 100, 370–378. [Google Scholar] [CrossRef] [PubMed]
  30. DeMauro, S.B. The impact of bronchopulmonary dysplasia on childhood outcomes. Clin. Perinatol. 2018, 45, 439–452. [Google Scholar] [CrossRef]
  31. Cheong, J.L.; Doyle, L.W. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin. Perinatol. 2018, 42, 478–484. [Google Scholar] [CrossRef]
  32. Anderson, P.J.; Doyle, L.W. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin. Perinatol. 2006, 30, 227–232. [Google Scholar] [CrossRef]
  33. Schmidt, B.; Roberts, R.S.; Davis, P.G.; Doyle, L.W.; Asztalos, E.V.; Opie, G.; Bairam, A.; Solimano, A.; Arnon, S.; Sauve, R.S.; et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J. Pediatr. 2015, 167, 982–986.e2. [Google Scholar] [CrossRef] [PubMed]
  34. DePaz, E.J.; Aghai, Z.; Konduri, G.G. Severe intraventricular hemorrhage, a marker of severe retinopathy of prematurity. Pediatr. Res. 1999, 45, 194. [Google Scholar] [CrossRef][Green Version]
  35. Watts, P.; Adams, G.G.W.; Thomas, R.M.; Bunce, C. Intraventricular haemorrhage and stage 3 retinopathy of prematurity. Br. J. Ophthalmol. 2000, 84, 596–599. [Google Scholar] [CrossRef]
  36. Foos, R.Y. Retinopathy of prematurity. Retina 1987, 7, 260–276. [Google Scholar] [CrossRef]
  37. Ng, Y.K.; Fielder, A.R.; Levene, M.I.; Trounce, J.Q.; McLellan, N. Are severe acute retinopathy of prematurity and severe periventricular leucomalacia both ischaemic insults? Br. J. Ophthalmol. 1989, 73, 111–114. [Google Scholar] [CrossRef] [PubMed]
  38. Leversen, K.T.; Sommerfelt, K.; Rønnestad, A.; Kaaresen, P.I.; Farstad, T.; Skranes, J.; Støen, R.; Elgen, I.B.; Rettedal, S.; Eide, G.E.; et al. Prediction of neurodevelopmental and sensory outcome at 5 years in norwegian children born extremely preterm. Pediatrics 2011, 127, e630–e638. [Google Scholar] [CrossRef]
  39. Ricci, D.; Lucibello, S.; Orazi, L.; Gallini, F.; Staccioli, S.; Serrao, F.; Olivieri, G.; Quintiliani, M.; Sivo, S.; Rossi, V.; et al. Early visual and neuro-development in preterm infants with and without retinopathy. Early Hum. Dev. 2020, 148, 105134. [Google Scholar] [CrossRef]
  40. Drost, F.J.; Keunen, K.; Moeskops, P.; Claessens, N.H.P.; Van Kalken, F.; Išgum, I.; Voskuil-Kerkhof, E.S.M.; Groenendaal, F.; De Vries, L.S.; Benders, M.J.N.L.; et al. Severe retinopathy of prematurity is associated with reduced cerebellar and brainstem volumes at term and neurodevelopmental deficits at 2 years. Pediatr. Res. 2018, 83, 818–824. [Google Scholar] [CrossRef] [PubMed]
  41. Sveinsdóttir, K.; Ley, D.; Hövel, H.; Fellman, V.; Huppi, P.S.; Smith, L.E.; Hellström, A.; Pupp, I.H. Relation of retinopathy of prematurity to brain volumes at term equivalent age and developmental outcome at 2 years of corrected age in very preterm infants. Neonatology 2018, 114, 46–52. [Google Scholar] [CrossRef] [PubMed]
  42. Morrone, M.C. Brain development: Critical periods for cross-sensory plasticity. Curr. Biol. 2010, 20, R934–R936. [Google Scholar] [CrossRef] [PubMed][Green Version]
  43. Lickliter, R. The integrated development of sensory organization. Clin. Perinatol. 2011, 38, 591–603. [Google Scholar] [CrossRef]
Brainsci 11 00699 g001
Figure 1. Flow chart of study population. IVH, intraventricular hemorrhage; PVL, periventricular hemorrhage; Bayley-III, Bayley Scales of Infant and Toddler Development 3rd Edition; NDI, neurodevelopment impairment.
Figure 1. Flow chart of study population. IVH, intraventricular hemorrhage; PVL, periventricular hemorrhage; Bayley-III, Bayley Scales of Infant and Toddler Development 3rd Edition; NDI, neurodevelopment impairment.
Brainsci 11 00699 g001
Table 1. Perinatal characteristics of study population.
Table 1. Perinatal characteristics of study population.
No IVH (n = 195)Low-Grade IVH (n = 45)p-Value
GA (week)30.3 (28.3–32)28.4 (26.4–30.4)<0.001
Birth weight (g)1230 (980–1340)920 (680–1210)<0.001
SGA49 (25.4)12 (27.3)0.849
IVF95 (48.7)21 (46.7)0.869
Male98 (50.3)26 (57.8)0.410
C/S120 (61.5)30 (66.7)0.609
hCAM68 (36)22 (51.2)0.083
PPROM >18 h52 (27.8)19 (43.2)0.068
Oligohydramnios36 (20.2)13 (31)0.150
PIH26 (13.6)9 (20.9)0.239
No ACS34 (17.7)6 (13.6)0.516
Data are shown as the n (%) or median (interquartile range). Abbreviations: ACS, antenatal steroid; C/S, cesarean section; GA, gestational age; hCAM, histologic chorioamnionitis; IVF, in vitro fertilization; n, number in group; PIH, pregnancy-induced hypertension; PPROM, preterm premature rupture of membrane; SGA, small for gestational age.
Table 2. Neonatal morbidities of study population.
Table 2. Neonatal morbidities of study population.
No IVH (n = 195)Low-Grade IVH (n = 45)p-Value
RDS80 (41)32 (71.1)<0.001
Treated PDA52 (26.7)20 (44.4)0.029
Moderate to severe BPD51 (26.6)18 (40)0.074
Any stage ROP40 (20.7)17 (37.8)0.016
Severe ROP10 (5.1)6 (13.3)0.088
NEC7 (3.6)3 (6.7)0.403
Sepsis9 (4.6)4 (8.9)0.273
Hospital stay (days)53 (32–79)73 (55–95.5)<0.001
Data are shown as the n (%) or median (interquartile range). Abbreviations: BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; n, number in group; NEC, necrotizing enterocolitis; PDA, patent ductus arteriosus; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity.
Table 3. Neurodevelopmental outcomes at 18–24 months of corrected age.
Table 3. Neurodevelopmental outcomes at 18–24 months of corrected age.
No IVH (n = 195)Low-Grade IVH (n = 45)p-Value
Neurodevelopmental impairment19 (9.7)6 (13.3)0.430
Cerebral palsy1 (0.5)0 (0)1.000
Hearing loss---
Blindness---
Bayley-III(n = 146)(n = 36)
Cognitive domain100 (90–105)90 (87.5–110)0.484
Language domain97 (86–106)90 (79–100)0.025
Motor domain97 (88–103)97 (88–100)0.617
Cognitive and language <8511 (7.5)3 (8.3)1.000
Motor <8515 (10.3)6 (16.7)0.380
Data are shown as the n (%) or median (interquartile range). Abbreviations: Bayley-III, Bayley Scales of Infant and Toddler Development-Third edition; IVH, intraventricular hemorrhage.
Table 4. Univariate and multivariate analysis for combined neurodevelopmental impairment at 18–24 months of corrected age.
Table 4. Univariate and multivariate analysis for combined neurodevelopmental impairment at 18–24 months of corrected age.
Univariate AnalysisMultivariate Analysis
OR95% CIp-ValueAdjusted OR95% CIp-ValueVIF
GA (week)0.90(0.77–1.04)0.1411.00(0.75–1.33)0.9862.830
SGA3.07(1.32–7.16)0.0096.82(1.77–26.31)0.0052.670
RDS1.82(0.78–4.24)0.1632.44(0.57–10.44)0.2281.810
Treated PDA1.65(0.70–3.86)0.2530.87(0.29–2.67)0.8141.810
Moderate to severe BPD5.33(2.23–12.78)0.0003.21(1.03–10.0)0.0441.680
NEC4.05(0.98–16.80)0.0541.94(0.34–11.08)0.4571.330
Severe ROP8.90(2.97–26.71)0.0005.67(1.13–28.40)0.0351.230
Sepsis4.36(1.24–15.38)0.0223.71(0.72–19.03)0.1161.120
Low-grade IVH1.43(0.53–3.80)0.4790.71(0.21–2.46)0.5941.080
Abbreviations: BPD, bronchopulmonary dysplasia; CI, confidence interval; GA, gestational age; IVH, intraventricular hemorrhage; n, number in group; NEC, necrotizing enterocolitis; OR, odds ratio; PDA, patent ductus arteriosus; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity; SGA, small for gestational age; VIF, variance inflation factor.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bae, S.P.; Shin, S.H.; Yoon, Y.M.; Kim, E.-K.; Kim, H.-S. Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury. Brain Sci. 2021, 11, 699. https://doi.org/10.3390/brainsci11060699

AMA Style

Bae SP, Shin SH, Yoon YM, Kim E-K, Kim H-S. Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury. Brain Sciences. 2021; 11(6):699. https://doi.org/10.3390/brainsci11060699

Chicago/Turabian Style

Bae, Seong Phil, Seung Han Shin, Young Mi Yoon, Ee-Kyung Kim, and Han-Suk Kim. 2021. "Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury" Brain Sciences 11, no. 6: 699. https://doi.org/10.3390/brainsci11060699

APA Style

Bae, S. P., Shin, S. H., Yoon, Y. M., Kim, E.-K., & Kim, H.-S. (2021). Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury. Brain Sciences, 11(6), 699. https://doi.org/10.3390/brainsci11060699

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop